pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,064 catalysts · 4,728 grant · 4,365 device 510k · 3,359 8k filing · 3,180 approval · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 10 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×from 2024-12-06×clear all
type
  • grant4,728
  • device 510k4,365
  • 8k filing3,359
  • approval3,180
  • device pma2,000
  • device recall2,000
  • recall
1,064
  • device adverse event1,000
  • earnings584
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Dec 9, 2024

    37
    ›Dec 11, 2024recall615d agoAmerisource Health Services LLC recall (Cls II)Aurobindo Pharma Ltd

    Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St., St. Louis, MO 63139 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAurobindo Pharma USA Inc recall (Cls II)Aurobindo Pharma USA Inc

    Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India. — Reason: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-554-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAurobindo Pharma USA Inc recall (Cls II)Aurobindo Pharma USA Inc

    Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India. — Reason: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAvKARE recall (Cls II)AvKare LLC

    Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-901-28 — Reason: Labeling: Label Mix-Up — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAmerisource Health Services LLC recall (Cls II)Aurobindo Pharma Ltd

    Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 Capsules, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-562-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAmerican Regent, Inc. recall (Cls II)American Regent Inc

    Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-534-01 (vial), NDC: 49230-534-25 (25 x 5 mL/vial cartons). — Reason: Presence of Particulate Matter: Potential for glass delamination from the vials. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoACCORD HEALTHCARE, INC. recall (Cls II)HCA Healthcare, Inc.

    Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17 — Reason: Subpotent drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAmerican Regent, Inc. recall (Cls II)American Regent Inc

    Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451, NDC: 49230-530-01 (vial), NDC: 49230-530-10 (10 x 2.5mL/vial cartons), NDC: 49230-530-25 (25 x 2.5mL/vial cartons). — Reason: Presence of Particulate Matter: Potential for glass delamination from the vials. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAvKARE recall (Cls II)AvKare LLC

    Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30 — Reason: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    Array Liquid Antiseptic Handwash, Chloroxylenol 0.1%, NET CONTENTS: 128 FL OZ (1 GAL) 3.785 L, FOR DISTRIBUTION EXCLUSIVELY BY GORDON FOOD SERVICE, WYOMING, MI 49509 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoBoulla LLC recall (Cls I)Amzell Limited

    ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com — Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoLannett Company Inc. recall (Cls II)Lannett Co Inc

    Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37 — Reason: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity. — Status: Terminated

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGeneritech Corporation recall (Cls II)MADE IN USA INC.

    10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your Rx, Nature + Science, 1 fl. oz., 30 mL Bottle, For Professional Use Only, Only YourRx Inc., Chatsworth, CA 91311, Made in USA, Onlyyourrx.com. — Reason: CGMP Deviations: Inconsistency in the water systems. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoBoulla LLC recall (Cls I)Amzell Limited

    VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com — Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoZydus Pharmaceuticals (USA) Inc recall (Cls III)LB PHARMACEUTICALS INC

    Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94. Packaged in sachets — Reason: Labeling: Not Elsewhere Classified - Wrong NDC number — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAvKARE recall (Cls II)AvKare LLC

    Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-461-30 — Reason: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    boardwalk ANTIBACTERIAL HANDSOAP REFILL, Chloroxylenol 0.1%, 1 gal. (3.78 L), Manufactured for Essendant Co., One Parkway North, Deerfield, IL 60015 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoBoulla LLC recall (Cls I)Amzell Limited

    PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com — Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoBoulla LLC recall (Cls I)Amzell Limited

    ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.com — Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAvKARE recall (Cls II)AvKare LLC

    Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-459-30 — Reason: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceuticals, Inc., East Brunswick, NJ — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAmerisource Health Services LLC recall (Cls II)Aurobindo Pharma Ltd

    Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-413-06 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 Gallon, 128 Ounces, 3.785 Liters, Royal Corporation, 10232 Palm Drive, Santa Fe Springs, CA 90670 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-850-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-553-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAmerican Regent, Inc. recall (Cls II)American Regent Inc

    Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, American Regent, Inc. Shirley, NY 11967, NDC: 0517-2340-01 (vial), NDC: 0517-2340-10 (10 x 5 mL/vial cartons), NDC: 0517-2340-25 (25 x 5 mL/vial cartons). — Reason: Presence of Particulate Matter: Potential for glass delamination from the vials. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoGlenmark Pharmaceuticals Inc., USA recall (Cls II)LB PHARMACEUTICALS INC

    Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-851-01. — Reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAurobindo Pharma USA Inc recall (Cls II)Aurobindo Pharma USA Inc

    Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India. 90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05 — Reason: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoMidlab Incorporated recall (Cls II)

    MAXIM Assure Antibacterial, Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303 — Reason: cGMP Deviations: Out of specification results for micro in hand soap products. — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoRising Pharma Holding, Inc. recall (Cls II)CHINA PHARMA HOLDINGS, INC.

    Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60 — Reason: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 11, 2024recall615d agoAvKARE recall (Cls II)AvKare LLC

    Sunitinib Malate Capsules, 25 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-902-28 — Reason: Labeling: Label Mix-Up — Status: Ongoing

    full page →fda recalls ↗

    Week of Dec 16, 2024

    13
    ›Dec 18, 2024recall608d agoViatris Inc recall (Cls II)Viatris Inc

    Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC 0378-1815-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. — Reason: Superpotent Drug and Subpotent Drug: potency failures obtained — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall
    ← prev
    page 1 of 22
    next →
    608d ago
    Viatris Inc recall (Cls II)Viatris Inc

    Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. — Reason: Superpotent Drug and Subpotent Drug: potency failures obtained — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoViatris Inc recall (Cls II)Viatris Inc

    Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. — Reason: Superpotent Drug and Subpotent Drug: potency failures obtained — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-445-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoLNK International, Inc. recall (Cls II)ICF International, Inc.

    Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Guaifenesin 200 mg, Phenylephrine HCl 5 mg); Night - 56 coated caplets blister pack; (Acetaminophen 325mg, Dextromethorphan HBr 10 mg, Doxylamine succinate 6.25 mg, Phenylephrine HCl 5 mg); Manufactured BY: LNK International, Inc. FOR: Costco Wholesale Corporation. NDC# 63981-795-81 — Reason: CGMP Deviations: Released product should have been rejected. — Status: Terminated

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoViatris Inc recall (Cls II)Viatris Inc

    Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. — Reason: Superpotent Drug and Subpotent Drug: potency failures obtained — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoViatris Inc recall (Cls II)Viatris Inc

    Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-count bottles (NDC 0378-1819-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. — Reason: Superpotent Drug and Subpotent Drug: potency failures obtained — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoMylan Institutional, Inc. recall (Cls II)Mylan Institutional Inc

    Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20 — Reason: Subpotent and Superpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Dec 18, 2024recall608d agoDr. Reddy's Laboratories, Inc. recall (Cls III)DR REDDYS LABORATORIES LTD

    Javygtor (sapropterin dihydrochloride) Tablets 100mg, 120-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 Made in India, NDC 43598-096-04. — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing

    full page →fda recalls ↗
    $CPHI0.7101-0.82%
    $LBRX47.77+7.92%
    $LBRX47.77+7.92%
    $LBRX47.77+7.92%
    $HCA404.68-1.71%
    $USDW
    $LBRX47.77+7.92%
    $LBRX47.77+7.92%
    $CPHI0.7101-0.82%
    $CPHI0.7101-0.82%
    $LBRX47.77+7.92%
    $VTRS16.23+1.18%
    $ICFI88.39-1.00%
    $VTRS16.23+1.18%
    $VTRS16.23+1.18%
    $LBRX47.77+7.92%
    $VTRS16.23+1.18%
    $VTRS16.23+1.18%
    $RDY12.27-1.21%